Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,619
in 1 filing, $6K under 10b5-1 plans

Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Prener Anne −$6K Director sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2025-02-18 Rovaldi Christopher Chief Operating Officer Grant or award +60,000 60,000
2024-02-13 Rovaldi Christopher CHIEF OPERATING OFFICER Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2023-02-16 Rovaldi Christopher Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +100,000 100,000
2022-04-06 Rovaldi Christopher Chief Operating Officer Option exercise +1,728 $16.00 $28K 1,728
2022-04-06 Rovaldi Christopher Chief Operating Officer Sale −1,728 $65.00 $112K 0
2022-04-06 Rovaldi Christopher Chief Operating Officer Option exercise · Employee Stock Option (right to buy) −1,728 8,002
2022-04-01 Rovaldi Christopher Chief Operating Officer Option exercise +864 $16.00 $14K 864
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −2 $54.34 $109 862
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −104 $56.20 $6K 758
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −287 $56.89 $16K 471
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −366 $57.97 $21K 105
2022-04-01 Rovaldi Christopher Chief Operating Officer Sale −105 $58.83 $6K 0
2022-04-01 Rovaldi Christopher Chief Operating Officer Option exercise · Employee Stock Option (right to buy) −864 9,730
2022-02-01 Rovaldi Christopher Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +100,000 100,000

Page 1 of 1 · 14 trades